RxEars Rxi vs Signia Pure C&G BCT IX

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.

The Signia Pure C&G BCT IX is a premium behind-the-ear prescription hearing aid released in 2025, earning an A grade with a SoundScore of 4.4/5 in our lab testing. Priced at $3,398, it ranks #16 among 39 prescription hearing aids tested. In our standardized testing, this device demonstrates particular strength in own-voice comfort, scoring 3.8/5—a solid result that sits 1.10 points above the category average. This makes it a noteworthy option for users who prioritize natural sound quality when speaking. Speech clarity also performs well, with speech-in-quiet at 3.8/5 (+0.39 points above average) and speech-in-noise at 2.5/5 (+0.43 points above average), though the latter remains mixed in absolute terms despite beating the category benchmark. Feedback handling presents an interesting picture: at 4.2/5, it's strong in absolute terms, though it falls 0.52 points below the category average of 4.72/5. Music streaming scores 2.7/5, essentially matching the category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. While the Pure C&G BCT IX delivers solid overall performance, shoppers in this premium price tier should note that competitors like the Phonak Sphere Infinio and Oticon Intent score higher in our testing. Budget-conscious buyers may also find comparable sound quality at lower price points from options like the Rexton Reach R-Li T80 at Costco. This hearing aid is best suited for users who value own-voice naturalness and reliable speech clarity in everyday listening situations.